167 related articles for article (PubMed ID: 27644897)
1. Biotechnological interventions for harnessing podophyllotoxin from plant and fungal species: current status, challenges, and opportunities for its commercialization.
Kumari A; Singh D; Kumar S
Crit Rev Biotechnol; 2017 Sep; 37(6):739-753. PubMed ID: 27644897
[TBL] [Abstract][Full Text] [Related]
2. [Research progress in biosynthesis of podophyllotoxin and its derivatives].
Meng Z; Yao T; Zhao W; Li H; Tang YJ
Sheng Wu Gong Cheng Xue Bao; 2021 Jun; 37(6):2026-2038. PubMed ID: 34227292
[TBL] [Abstract][Full Text] [Related]
3. Expressed sequence tags and molecular cloning and characterization of gene encoding pinoresinol/lariciresinol reductase from Podophyllum hexandrum.
Wankhede DP; Biswas DK; Rajkumar S; Sinha AK
Protoplasma; 2013 Dec; 250(6):1239-49. PubMed ID: 23653238
[TBL] [Abstract][Full Text] [Related]
4. Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinically useful anticancer drugs.
Giri A; Lakshmi Narasu M
Cytotechnology; 2000 Oct; 34(1-2):17-26. PubMed ID: 19003377
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of (-)-deoxypodophyllotoxin and (-)-epipodophyllotoxin via a multi-enzyme cascade in E. coli.
Decembrino D; Raffaele A; Knöfel R; Girhard M; Urlacher VB
Microb Cell Fact; 2021 Sep; 20(1):183. PubMed ID: 34544406
[TBL] [Abstract][Full Text] [Related]
6. Comparative whole-transcriptome analysis in Podophyllum species identifies key transcription factors contributing to biosynthesis of podophyllotoxin in P. hexandrum.
Kumar P; Jaiswal V; Pal T; Singh J; Chauhan RS
Protoplasma; 2017 Jan; 254(1):217-228. PubMed ID: 26733390
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome-wide identification and characterization of CAD isoforms specific for podophyllotoxin biosynthesis from Podophyllum hexandrum.
Bhattacharyya D; Hazra S; Banerjee A; Datta R; Kumar D; Chakrabarti S; Chattopadhyay S
Plant Mol Biol; 2016 Sep; 92(1-2):1-23. PubMed ID: 27387305
[TBL] [Abstract][Full Text] [Related]
8. The role of biotechnology in the production of the anticancer compound podophyllotoxin.
Lata H; Mizuno CS; Moraes RM
Methods Mol Biol; 2009; 547():387-402. PubMed ID: 19521861
[TBL] [Abstract][Full Text] [Related]
9. Biotechnological aspects of the production of the anticancer drug podophyllotoxin.
Farkya S; Bisaria VS; Srivastava AK
Appl Microbiol Biotechnol; 2004 Oct; 65(5):504-19. PubMed ID: 15378293
[TBL] [Abstract][Full Text] [Related]
10. Expression analysis of biosynthetic pathway genes vis-à-vis podophyllotoxin content in Podophyllum hexandrum Royle.
Kumar P; Pal T; Sharma N; Kumar V; Sood H; Chauhan RS
Protoplasma; 2015 Sep; 252(5):1253-62. PubMed ID: 25586110
[TBL] [Abstract][Full Text] [Related]
11. Mucor fragilis as a novel source of the key pharmaceutical agents podophyllotoxin and kaempferol.
Huang JX; Zhang J; Zhang XR; Zhang K; Zhang X; He XR
Pharm Biol; 2014 Oct; 52(10):1237-43. PubMed ID: 24863281
[TBL] [Abstract][Full Text] [Related]
12. Relationship between podophyllotoxin accumulation and soil nutrients and the influence of Fe2+ and Mn2+ on podophyllotoxin biosynthesis in Podophyllum hexandrum tissue culture.
Li MF; Li W; Yang DL; Zhou LL; Li TT; Su XM
Plant Physiol Biochem; 2013 Oct; 71():96-102. PubMed ID: 23906505
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Podophyllum peltatum accessions for podophyllotoxin production.
Moraes RM; Bedir E; Barrett H; Burandt C; Canel C; Khan IA
Planta Med; 2002 Apr; 68(4):341-4. PubMed ID: 11988859
[TBL] [Abstract][Full Text] [Related]
14. [Interest of lignans in prevention and treatment of cancers].
Lamblin F; Hano C; Fliniaux O; Mesnard F; Fliniaux MA; Lainé E
Med Sci (Paris); 2008 May; 24(5):511-9. PubMed ID: 18466729
[TBL] [Abstract][Full Text] [Related]
15. Chilling temperature stimulates growth, gene over-expression and podophyllotoxin biosynthesis in Podophyllum hexandrum Royle.
Yang L; Sun P; Li MF
Plant Physiol Biochem; 2016 Oct; 107():197-203. PubMed ID: 27314513
[TBL] [Abstract][Full Text] [Related]
16. Enhanced production of podophyllotoxin by Podophyllum hexandrum using in situ cell retention bioreactor.
Chattopadhyay S; Bisaria VS; Srivastava AK
Biotechnol Prog; 2003; 19(3):1026-8. PubMed ID: 12790673
[TBL] [Abstract][Full Text] [Related]
17.
Suzuki S; Suzuki H; Tanaka K; Yamamura M; Shibata D; Umezawa T
Plant Biotechnol (Tokyo); 2019; 36(2):113-118. PubMed ID: 31768112
[TBL] [Abstract][Full Text] [Related]
18. Stress-mediated adaptive response leading to genetic diversity and instability in metabolite contents of high medicinal value: an overview on Podophyllum hexandrum.
Gupta ML; Dutta A
OMICS; 2011 Dec; 15(12):873-82. PubMed ID: 22181019
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing in predicting gene function in podophyllotoxin biosynthesis.
Marques JV; Kim KW; Lee C; Costa MA; May GD; Crow JA; Davin LB; Lewis NG
J Biol Chem; 2013 Jan; 288(1):466-79. PubMed ID: 23161544
[TBL] [Abstract][Full Text] [Related]
20. Effect of major nutrients on podophyllotoxin production in Podophyllum hexandrum suspension cultures.
Chattopadhyay S; Mehra RS; Srivastava AK; Bhojwani SS; Bisaria VS
Appl Microbiol Biotechnol; 2003 Jan; 60(5):541-6. PubMed ID: 12536253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
